Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 15, 2021

SELL
$56.61 - $80.46 $187,945 - $267,127
-3,320 Closed
0 $0
Q1 2021

Apr 12, 2021

SELL
$86.23 - $125.19 $190,654 - $276,795
-2,211 Reduced 39.97%
3,320 $308,000
Q4 2020

Jan 13, 2021

SELL
$79.17 - $111.47 $127,147 - $179,020
-1,606 Reduced 22.5%
5,531 $496,000
Q3 2020

Oct 23, 2020

BUY
$81.91 - $134.94 $37,678 - $62,072
460 Added 6.89%
7,137 $737,000
Q2 2020

Jul 16, 2020

BUY
$54.33 - $89.52 $362,761 - $597,725
6,677 New
6,677 $528,000
Q2 2019

Aug 01, 2019

SELL
$39.92 - $53.86 $1,437 - $1,938
-36 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$48.23 - $66.16 $1,736 - $2,381
36 New
36 $2,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $493M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Coastal Investment Advisors, Inc. Portfolio

Follow Coastal Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.